UK markets closed

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
21.52-0.60 (-2.71%)
At close: 03:33PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
36,476,000
34,114,000
34,099,000
33,754,000
30,821,000
Cost of revenue
12,813,000
11,603,000
11,704,000
11,863,000
10,241,000
Gross profit
23,663,000
22,511,000
22,395,000
21,891,000
20,580,000
Operating expenses
Research development
5,327,000
5,278,000
5,098,000
4,568,000
3,893,000
Selling general and administrative
11,392,000
10,975,000
11,456,000
11,402,000
9,915,000
Total operating expenses
15,872,000
15,828,000
16,171,000
15,599,000
13,516,000
Operating income or loss
7,791,000
6,683,000
6,224,000
6,292,000
7,064,000
Interest expense
788,000
777,000
856,000
885,000
771,000
Income before tax
6,522,000
5,442,000
6,968,000
6,221,000
4,800,000
Income tax expense
519,000
346,000
580,000
953,000
754,000
Income from continuing operations
6,003,000
5,096,000
6,388,000
5,268,000
4,046,000
Net income
5,114,000
4,385,000
5,749,000
4,645,000
3,623,000
Net income available to common shareholders
5,114,000
4,385,000
5,749,000
4,645,000
3,623,000
Basic EPS
-
0.88
1.16
0.94
0.74
Diluted EPS
-
0.87
1.14
0.93
0.73
Basic average shares
-
5,003,000
4,976,000
4,947,000
4,914,000
Diluted average shares
-
5,065,000
5,038,000
5,016,000
4,971,000
EBITDA
-
8,596,000
10,175,000
9,440,000
7,427,000